JP2020519265A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519265A5
JP2020519265A5 JP2019561819A JP2019561819A JP2020519265A5 JP 2020519265 A5 JP2020519265 A5 JP 2020519265A5 JP 2019561819 A JP2019561819 A JP 2019561819A JP 2019561819 A JP2019561819 A JP 2019561819A JP 2020519265 A5 JP2020519265 A5 JP 2020519265A5
Authority
JP
Japan
Prior art keywords
antibody
cell culture
collection
during
hydrogen peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019561819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519265A (ja
JP7453788B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/031542 external-priority patent/WO2018208743A1/en
Publication of JP2020519265A publication Critical patent/JP2020519265A/ja
Publication of JP2020519265A5 publication Critical patent/JP2020519265A5/ja
Priority to JP2023145991A priority Critical patent/JP2023182593A/ja
Application granted granted Critical
Publication of JP7453788B2 publication Critical patent/JP7453788B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019561819A 2017-05-09 2018-05-08 抗体製造の間のピンク色の形成を制御する方法 Active JP7453788B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023145991A JP2023182593A (ja) 2017-05-09 2023-09-08 抗体製造の間のピンク色の形成を制御する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762503615P 2017-05-09 2017-05-09
US62/503,615 2017-05-09
PCT/US2018/031542 WO2018208743A1 (en) 2017-05-09 2018-05-08 Method of controlling the formation of pink color during antibody manufacturing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023145991A Division JP2023182593A (ja) 2017-05-09 2023-09-08 抗体製造の間のピンク色の形成を制御する方法

Publications (3)

Publication Number Publication Date
JP2020519265A JP2020519265A (ja) 2020-07-02
JP2020519265A5 true JP2020519265A5 (https=) 2021-05-13
JP7453788B2 JP7453788B2 (ja) 2024-03-21

Family

ID=62751522

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019561819A Active JP7453788B2 (ja) 2017-05-09 2018-05-08 抗体製造の間のピンク色の形成を制御する方法
JP2023145991A Withdrawn JP2023182593A (ja) 2017-05-09 2023-09-08 抗体製造の間のピンク色の形成を制御する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023145991A Withdrawn JP2023182593A (ja) 2017-05-09 2023-09-08 抗体製造の間のピンク色の形成を制御する方法

Country Status (7)

Country Link
US (1) US12241107B2 (https=)
EP (1) EP3621989B1 (https=)
JP (2) JP7453788B2 (https=)
KR (1) KR102664829B1 (https=)
CN (1) CN110831964A (https=)
ES (1) ES2951287T3 (https=)
WO (1) WO2018208743A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7621284B2 (ja) 2020-01-31 2025-01-24 中外製薬株式会社 着色を抑制したポリペプチドを含む組成物の製造方法
KR20250069604A (ko) * 2022-09-15 2025-05-19 사노피 단백질 환원 민감성의 결정 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2689458B2 (ja) * 1988-02-09 1997-12-10 武田薬品工業株式会社 粒状ないし粉末状のビタミンｂ▲下１▼▲下２▼類含有組成物
JP2734709B2 (ja) * 1990-01-05 1998-04-02 東レ株式会社 インクジェット染色用布帛およびそれを用いてなるインクジェット染色法
SE525083C2 (sv) * 2003-04-23 2004-11-23 Kemira Kemi Ab Sätt att behandla rötslam
AU2005310305A1 (en) * 2004-10-22 2006-06-08 Amgen Inc. Methods for refolding polypeptides
EP1971488A2 (en) * 2005-12-05 2008-09-24 Lifeline Cell Technology Cell culture medium container assembly
KR102055873B1 (ko) * 2007-07-09 2019-12-13 제넨테크, 인크. 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
CA2765220A1 (en) 2009-07-14 2011-01-20 Biogen Idec Ma Inc. Methods for inhibiting yellow color and peroxide formation in a composition
KR20160088930A (ko) 2013-12-04 2016-07-26 이뮤노젠 아이엔씨 항체 생산용 조성물 및 항체 생성 방법

Similar Documents

Publication Publication Date Title
Klein et al. Engineering therapeutic bispecific antibodies using CrossMab technology
JP2023081967A (ja) ジスルフィド結合の還元を最小限にする抗体製造法
CN105378086B (zh) 用于控制重组蛋白质中c端赖氨酸、半乳糖和唾液酸含量的制造方法
JP2019104735A (ja) 抗体を精製するための連続的多工程法
SI2904092T1 (en) Ingredients and procedures for the production of glycoproteins
JP2017538446A5 (https=)
RU2018146533A (ru) Антитела к cd40 и пути их применения
CN105713835A (zh) 一种基于微流控芯片的多功能区域细胞三维共培养方法
JP2013530156A5 (https=)
SI2634243T1 (en) Improved process for the culturing of cells
RU2018141777A (ru) Биспецифичные антитела, нацеленные на egfr и her2
JP2007529223A5 (https=)
JP2020519265A5 (https=)
TW200835542A (en) Method of isolating biomacromolecules using low pH and divalent cations
JP2021519108A5 (https=)
JP2024147613A (ja) 連続細胞培養の方法
EP4008774A1 (en) Cell culture method and application thereof based on high-density and continuous inoculation
FR2541304B1 (https=)
FI3063287T3 (fi) Monensiinin käyttö rekombinanttiproteiinien glykosylaation säätelyyn
CA2402593A1 (en) Monoclonal antibodies to the human ldl receptor, their production and use
ATE337395T1 (de) Hybridomzelllinie g250 und deren verwendung zur herstellung monoklonaler antikörper
Yokoyama Monoclonal antibody supernatant and ascites fluid production
BR112020019409A2 (pt) Processo de fluxo completo para a purificação de proteínas recombinantes
CN101235086B (zh) 重组人抗狂犬病毒抗体
RU2009124226A (ru) Гуманизированные антитела и fab, связывающиеся с антигеном f1 из yersinia pestis, и способ их получения с использованием дрожжей